“Experience in Switching Monoclonal Antibodies in a Patient With Severe Refractory Atopic Dermatitis: From Dupilumab to Abrocitinib. Case Report ”. Revista Alergia México, vol. 72, no. 4, Dec. 2025, pp. 382-5, https://doi.org/10.29262/ram.v72i4.1547.